Home » Topics » BioWorld Science

BioWorld Science
RSS

French researchers patent new beta-lactamase inhibitors

Oct. 4, 2018

Yogee's Bioinnovations discloses cathepsin D and angiogenesis inhibitors

Oct. 4, 2018

Pfizer identifies LRRK2 inhibitors

Oct. 4, 2018

Encouraging initial data presented from two ongoing studies of Trappsol Cyclo in NPC

Oct. 4, 2018

OncoTherapy Science patents SUV39H2 inhibitors

Oct. 4, 2018

Go Therapeutics and Roche enter license agreement to develop glycotargeting bispecific antibody

Oct. 4, 2018

Humira goes to Stockholm: Three win Chemistry Nobels for protein engineering methods

Oct. 4, 2018

A Finnish founder mutation in junctophilin-2 causes hypertrophic cardiomyopathy

Oct. 4, 2018

Researchers identify Lrrc55 as potential new target in pancreatic beta cells

Oct. 4, 2018

CD44 as novel therapeutic target in diabetes

Oct. 4, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...